RNA Manufacturing Videos

31. OligoPilot™ Oligonucleotide Synthesizer Product Overview 2/3/2025

    Meet our OligoPilot™ oligonucleotide synthesizer – the next generation oligo synthesizer with scales to 150 mmol.

32. Chromatography And Column-Free Processes 10/16/2023

    Listen in on a discussion surrounding questions about chromatography and column-free processes in the development of mRNA vaccines and therapeutics.

33. Considerations To Better Understand/Mitigate Raw Material Variability 4/24/2023

    In this Bioprocess Online Live panel discussion featuring John Stubenrauch, Ph.D., Chief Operations Officer at Nutcracker Therapeutics, and Hari Pujar, Ph.D., Chief Operating Officer at Tessera, explore the impact of and how to potentially mitigate issues posed by raw material variability.

34. Next Generation GMP Facility For CRISPR Based Therapies 3/14/2023

    Explore a state-of-the-art GMP facility focused on CRISPR based Cell and Gene therapies with helping temperature controlled warehouse and multiple synthesis suites.

35. Your AKTA Oligosynt™ System : It's More Than A Machine 2/9/2026

    Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.

36. mRNA Capabilities 3/4/2025

    Discover how our advanced capabilities in Hopkinton, MA, are overcoming the challenges of large-scale RNA therapeutic manufacturing, enabling the efficient production of complex srRNA and mRNA therapies.

37. How To Select The Right Bioanalysis CRO For Your Program 11/3/2025

    The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?

38. Shaping Therapeutic Development With Cutting-Edge CRISPR Nucleases 6/4/2025

    Gain an understanding of how an advanced nuclease portfolio is designed to support CRISPR-based cell and gene therapy development, providing scientists with the best solutions for therapeutic success.

39. Scale-Up And Production Of Key Lipids Used In mRNA Delivery Systems 2/13/2025

    Discover key strategies for overcoming challenges in the industrial-scale production of ionizable and PEG lipids to optimize mRNA vaccine formulation and address critical manufacturing requirements.

40. Durable Liquid Nanoparticle (LNP) Systems 12/6/2024

    Discover the benefits of an LNP system that offers unparalleled durability and sustainability. Eliminate wear parts, plastic waste, and running costs with a system designed for long-term performance and minimal environmental impact.